Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30°C

Vox Sanguinis

Volumn 98, Issue 2, 2010, Pages 108-115

  Bihm, D J ^a   Ettinger, A ^a   Buytaert Hoefen, K A ^a   Hendrix, B K ^a   Maldonado Codina, G ^a   Rock, G ^b   Giclas, P C ^c   Goodrich, R P ^a  

^a CaridianBCT Biotechnologies LLC   (United States)

^b UNIVERSITY OF OTTAWA   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

Author keywords

Fresh frozen plasma; Mirasol; Pathogen reduction; Protein quality; Riboflavin

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; FRESH FROZEN PLASMA; PLASMA PROTEIN; PROTEIN; PROTHROMBIN; RIBOFLAVIN;

ANTICOAGULATION; APHERESIS; ARTICLE; BLOOD; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD SAMPLING; BLOOD STORAGE; CONTROLLED STUDY; FIBRINOGEN BLOOD LEVEL; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN QUALITY; ULTRAVIOLET RADIATION; BLOODBORNE BACTERIUM; CRYOPRESERVATION; DRUG EFFECTS; ISOLATION AND PURIFICATION; PHYSIOLOGY; PLASMA; PROCEDURES; RADIATION RESPONSE;

BLOOD COMPONENT REMOVAL; BLOOD PRESERVATION; BLOOD PROTEINS; BLOOD-BORNE PATHOGENS; CRYOPRESERVATION; HUMANS; PLASMA; RIBOFLAVIN; ULTRAVIOLET RAYS;

EID: 74549226197     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2009.01238.x     Document Type: Article

References (51)

1. Blajchman MA, Goldman M, Baeza F : Improving the bacteriological safety of platelet transfusions. Transfus Med Rev 2004 18 : 11 24
2. Marques A, Torres S, Davis JM : The current infectious risks of transfusions. Surgical Infections 2005 6 (Suppl.1 23 31
3. Leiby DA, Lenes BA, Tibbals MA, Tames-Olmedo MT : Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999 341 : 1237 1239
4. Wu CG, Mason B, Jong J, Erdman D, McKernan L, Oakley M, Soucie M, Evatt B, Yu MY : Parvovirus B19 transmission by a high-purity Factor VIII concentrate. Transfusion 2005 45 : 1003 1010
5. Cangelosi JJ, Sarvat B, Sarria JC, Herwaldt BL, Indrikovs AJ : Transmission of Babesia microti by blood transfusion in Texas. Vox Sang 2008 95 : 331 334
6. Hellstern P : Solvent/detergent-treated plasma: composition, efficacy, and safety. Current Opinions in Hematology 2004 11 : 346 350
7. Williamson LM, Cardigan R, Prowse CV : Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety? Transfusion 2003 43 : 1322 1339
8. Corash L, Lin L : Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease. Bone Marrow Transplant 2004 33 : 1 7
9. Lin L, Dikeman R, Molini B, Lukehart SA, Lane R, Dupuis K, Metzel P, Corash L : Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion 2004 44 : 1496 1504
10. Lin L, Hanson CV, Alter HJ, Jauvin V, Bernard KA, Murthy KK, Metzel P, Corash L : Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion 2005 45 : 580 590
11. Zempleni J, Galloway JR, McCormick DB : Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. The American Journal of Clinical Nutrition 1996 63 : 54 66
12. Unna K, Greslin JG : Studies on the toxicity and pharmacology of riboflavin. J Pharmacol 1942 76 : 75 80
13. Leclerc J : Influence of thiamine, riboflavin and vitamin B6 content in food on tissue content of these vitamins in the female lactating rat and young rats. Annales de la nutrition et de l'alimentation 1974 28 : 11 20
14. Kale H, Harikumar P, Nair PM, Kulkarni SB, Netrawali MS : Assessment of the genotoxic potential of riboflavin and lumiflavin. Mutat Res 1992 298 : 9 16
15. Kumar V, Lockerbie O, Keil SD, Ruane P, Platz M, Martin C : Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol 2004 80 : 15 21
16. Cadet J, Decarroz S, Wang Y, Midden W : Mechanisms and products of photosensitized degradation and related model compounds. Isr J Chem 1983 23 : 420 429
17. Joshi P : Comparison of the DNA damaging property of photosensitized riboflavin via singlet oxygen and superoxide mechanisms. Toxicol Lett 1985 26 : 211 217
18. Ennever J, Speck W : Photochemical reactions of riboflavin: covalent binding to DNA and to poly (dA) poly (dT). Pediatr Res 1983 17 : 234 236
19. Ravanat JL, Cadet J : Reaction of singlet oxygen with 2′-deoxyguanosine and DNA isolation and characterization of the main oxidation products. Chem Res Toxicol 1995 8 : 379 388
20. Horowitz B : Pathogen inactivated transfusion plasma: existing and emerging methods. Vox Sang 2002 83 : 429 436
21. Instructions for use (Product inserts for Methylene blue and Intercept): MacoPharma Disposable set for Viral attenuation of plasma NOTEURO13 2005-09-23 and Plasma Processing Set (INT31), Cerus Corp. Concord CA 2009
22. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP : Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004 44 : 877 885
23. Rentas F, Harman R, Gomez C, Salata J, Childs J, Silva T, Lippert L, Montgomery J, Richards A, Chan C, Jiang J, Reddy H, Li J, Goodrich R : Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model. Transfusion 2007 47 : 240 247
24. Goodrich L, Ghielli M, Hansen E, Woolum M, Gampp D, Goodrich R, Keil S : Riboflavin and UV light inactivate enveloped and non-enveloped viruses in platelet concentrates under conditions which maintain cell quality. Vox Sang 2002 83 : 111
25. Goodrich RP, Edrich RA, Li J, Seghatchian J : The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfusion and Apheresis Science 2006 35 : 5 17
26. Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R : Pathogen inactivation of Trypanosoma cruzi in plasma and platelets concentrates using riboflavin and ultraviolet light. Transfusion and Apheresis Science 2007 37 : 131 137
27. Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mende J, Reddy H, Goodrich R : Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang 2006 90 : 85 91
28. Sullivan JJ, Bounngaseng AS, Reddy HL, Keil SD, Goodrich RP : Inactivation of Plasmodium falciparum in Plasma and Platelet Concentrates with Riboflavin and UV Light (in press).
29. Tonnetti L, Proctor MC, Reddy HL, Goodrich RP, Leiby DA : Evaluation of Mirasol pathogen reduction technology system for reduction of Babesia Microti in apheresis platelets and plasma (in press).
30. Larrea L, Calabuig M, Roldán V, River J, Tsai H, De Cock P, Vicente V, Roig R : The influence of riboflavin photochemistry on plasma coagulation factors. Transfusion and Apheresis science 2009 (in press).
31. Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP : Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev 2008 22 : 133 153
32. Singh LS, Sawyer LS, Pinkoski KW, Dupuis JC, Hsu L, Lin L : Photochemical treatment of plasma with amotosalen and long wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 2006 46 : 1168 1177
33. Wieding JU, Hellstern P, Köhler M : Inactivation of viruses in fresh frozen plasma. Ann Hematol 1993 67 : 259 266
34. Doyle S, O'Brien P, Murphy K, Fleming C, O'Donnell J : Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coagul Fibrinolysis 2003 14 : 283 287
35. Aznar JA, Bonanad S, Montoro JM, Hurtado C, Cid AR, Soler MA, De Miguel A : Influence of Methylene Blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitate and cryosupernatants. Vox Sang 2000 7 : 156 160
36. De Valensart N, Rapaille A, Goossenaerts E, Irsch J, Lin L, Deneys V : Study of coagulation function in thawed apheresis plasma photochemical treatment by amotosalen and UVA. Vox Sang 2008 96 : 213 218
37. Riggert J, Humpe A, Legler TJ, Wolf C, Simson G, Köhler M : Filtration of methylene blue-photooxidized plasma: influence on coagulation and cellular contamination. Transfusion 2001 41 : 82 86
38. Zeiler T, Riess H, Wittmann G, Zlimmermann R, Muller C, Heuft HG, Huhn D : The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma. Transfusion 1994 34 : 685 689
39. Depasse F, Sensebe L, Seghatchian J, Andreu G, Samama M-M : The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerization indices. Transfusion and apheresis science 2005 33 : 63 69
40. Suotaka A-M, Blomback M, Chapman J : Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light. Transfusion 2003 43 : 568 575
41. Pinkoski L, Peterson T, Bayat J, Corash L : Coagulation factor activity in intercept plasma after storage for 24 months at -25°C. Vox Sang 2008 95, 1S : 288 289
42. Mintz PD, Bass N, Petz LD, Steadman R, Streiff M, McCullough J, Burks S, Wages D, Van Doren S Corash L : Photochemically treated fresh frozen plasma for transfusion of patients with acquired coagulopathy of liver disease. Blood 2009 107 : 3753 3760
43. Osselaer J-C, Debry C, Goffaux M, Pineau J, Calomme G, Dubuc E, Chatelain B, Vandendaele M-C, Hsu J, Rheinscmidt M Lin L : Coagulation function in fresh frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen. Transfusion 2008 48 : 108 117
44. Schlenke P, Hervig T, Isola H, Wiesel M-L, Klientz D, Pinkoski l, Singh Y, Lin L, Corash L, Cazernave J-P : Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers. Transfusion 2008 48 : 697 705
45. Bonagura V, Marchlevski R, Cox A, Rosenthal D : Biologic IgG level in primary immunodeficiency disease: The IgG level that protects against recurrent infection. J. Allergy and Clinical Immunology 2008 122 : 210 212
46. Garwood M, Cardigan RA, Drummond O, Hornsey V, Turner CP, Young D, Williamson LM, Prowse CV : The effect of methylene blue photoinactivation and methylene blue removal on the quality of fresh frozen plasma. Transfusion 2003 43 : 1238 1247
47. Flamholtz R, Jean HR, Barron JM, Barron BW : Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is it decreased protein S activity related to their development of deep venous thromboses? Journal of Clin. Apheresis 2000 15 : 169 172
48. Salge-Bartels U, Breitner-Ruddock S, Hunfeld A, Seitz R, Heiden M : Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe?. Trans Med 2006 16 : 266 275
49. Alvarez-Larrán A, Del Rio J, Ramirez C, Albo C, Peña F, Campos A, Cid J, Muncunill J, Sastre JL, Sanz C, Pereira A : Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Vox Sang 2004 86 : 246 251
50. Mintz PD, Neff A, MacKenzie M, Goodnough LT, Hillyer C, Kessler C, McCrae K, Menitove JE, Skikne BS, Damon L, Lopez-Plaza I, Rouault C, Crookston KP, Benjamin RJ, George J, Lin JS, Corash L, Conlan MG : A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic Purpura. Transfusion 2006 46 : 1693 1704
51. Evans G, Llewelyn C, Luddington R, Baglin TP, Williamson LM : Solvent/detergent fresh frozen plasma as primary treatment of acute thrombotic thrombocytopenic purpura. Clin Lab Haematol 1999 21 : 119 123